Pharvaris N.V.
PHVS
$14.00
$0.282.04%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 50.95M | 45.36M | 40.38M | 36.67M | 33.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 157.48M | 138.67M | 125.52M | 112.96M | 104.83M |
| Operating Income | -157.48M | -138.67M | -125.52M | -112.96M | -104.83M |
| Income Before Tax | -143.37M | -142.09M | -122.01M | -113.82M | -107.91M |
| Income Tax Expenses | 1.96M | 1.44M | 1.35M | 1.38M | 1.13M |
| Earnings from Continuing Operations | -145.33 | -143.53 | -123.36 | -115.19 | -109.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -145.33M | -143.53M | -123.36M | -115.19M | -109.05M |
| EBIT | -157.48M | -138.67M | -125.52M | -112.96M | -104.83M |
| EBITDA | -157.37M | -138.59M | -125.39M | -112.78M | -104.60M |
| EPS Basic | -2.69 | -2.81 | -2.58 | -2.68 | -2.83 |
| Normalized Basic EPS | -1.66 | -1.73 | -1.60 | -1.66 | -1.75 |
| EPS Diluted | -2.69 | -2.81 | -2.58 | -2.68 | -2.83 |
| Normalized Diluted EPS | -1.66 | -1.73 | -1.60 | -1.66 | -1.75 |
| Average Basic Shares Outstanding | 216.08M | 205.96M | 192.80M | 173.41M | 153.49M |
| Average Diluted Shares Outstanding | 216.08M | 205.96M | 192.80M | 173.41M | 153.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |